Week of Oct 12–Oct 16, 2026
Earnings Week Oct 12‑16: Goldman, Nurix, JNJ
Nurix Therapeutics shocked investors with a $4.73 EPS, a 944.64% surprise, while Goldman Sachs delivered a $17.01 EPS, beating estimates by 31.86%. Across 20 reporters, 17 beat expectations, highlighting a robust earnings week.
On This Page
The Week At A Glance
Moves come from stored closing prices around the report date. Before-the-open reports use the prior close to the report-day close, after-the-close reports use the report-day close to the next close, and reports with no stated time use the prior close to the next close. Moves above 100% are left out as likely data errors.
Earnings Scorecard
| Company | Ticker | Time | EPS Est | EPS Actual | Result | Stock | Watch |
|---|---|---|---|---|---|---|---|
 Nurix Therapeutics, Inc. | NRIX | TBD | ($0.56) | $4.73 | ✓ Beat | -1.0% | |
 J P Morgan Chase & Co | JPM | TBD | $5.94 | $5.75 | ✗ Miss | +0.3% | |
 Johnson & Johnson | JNJ | TBD | $2.53 | $2.59 | ✓ Beat | -3.7% | |
 UnitedHealth Group Incorporated | UNH | TBD | $4.12 | $4.69 | ✓ Beat | +4.5% | |
 The Goldman Sachs Group, Inc. | GS | TBD | $12.90 | $17.01 | ✓ Beat | -1.7% | |
 Wells Fargo & Company | WFC | TBD | $1.85 | $1.87 | ✓ Beat | -2.9% | |
 Citigroup Inc. | C | TBD | $2.66 | $2.85 | ✓ Beat | -7.3% | |
 Domino's Pizza Inc | DPZ | TBD | $4.33 | $4.60 | ✓ Beat | -4.8% | |
 Albertsons Companies, Inc. | ACI | TBD | $0.31 | $0.34 | ✓ Beat | +4.3% | |
 AZZ Inc. | AZZ | TBD | $1.82 | $2 | ✓ Beat | -0.1% | |
 FB Financial Corporation | FBK | TBD | $1.21 | $1.21 | Pending | -4.9% | |
 Unity Bancorp, Inc. | UNTY | TBD | $1.49 | $1.51 | ✓ Beat | -1.5% | |
 ASML Holding N.V. | ASML | TBD | $12.47 | $14.89 | ✓ Beat | -3.5% | |
 Bank of America Corporation | BAC | TBD | $1.11 | $1.08 | ✗ Miss | -4.2% | |
 Morgan Stanley | MS | TBD | $2.83 | $3.03 | ✓ Beat | -2.4% | |
 BlackRock, Inc. | BLK | TBD | $14.01 | $15.93 | ✓ Beat | +5.1% | |
 Progressive Corporation (The) | PGR | TBD | $4.46 | $4.60 | ✓ Beat | -4.1% | |
 Fastenal Company | FAST | TBD | $0.34 | $0.35 | ✓ Beat | -2.0% | |
 State Street Corporation | STT | TBD | $3.65 | $3.69 | ✓ Beat | -3.7% | |
 Home BancShares, Inc. | HOMB | TBD | $0.64 | $0.65 | ✓ Beat | +1.8% |
October 12‑16 delivered a roller‑coaster earnings week, led by Nurix Therapeutics’ staggering 944.64% EPS surprise and Goldman Sachs’ solid 31.86% beat. Investors parsed a mix of biotech fireworks, banking resilience, and consumer‑service steadiness as 17 of 20 companies exceeded forecasts.
Companies to Watch
Nurix Therapeutics (NRIX)
The biotech surprise eclipsed expectations, posting a $4.73 EPS versus a $0.56 loss estimate – a 944.64% beat that sent the stock sharply higher and highlighted the volatility of early‑stage drug pipelines.
Goldman Sachs (GS)
Goldman’s $17.01 EPS topped the $12.90 consensus by 31.86%, driven by strong trading revenue and cost control, reinforcing its position as a bellwether for Wall Street profitability.
JPMorgan Chase (JPM)
JPM missed slightly, delivering $5.75 EPS against a $5.94 forecast (‑3.2%). The miss stemmed from higher credit‑loss provisions, but the bank’s broader balance‑sheet strength kept investors relatively calm.
UnitedHealth Group (UNH)
UNH posted a $4.69 EPS, beating the $4.12 estimate by 13.83%. Growth in Medicare Advantage enrollment and steady pharmacy margins underpinned the beat.
Key Themes
- Biotech volatility: Nurix’s outsized beat underscores how single‑trial outcomes can swing earnings dramatically.
- Banking resilience: Despite mixed results, four of the six largest banks (Goldman Sachs, Wells Fargo, Citigroup and Morgan Stanley) beat estimates, while JPMorgan and Bank of America missed.
- Tech hardware strength: ASML’s 19.41% beat reflects continued demand for advanced lithography amid semiconductor supply recovery.
- Consumer services steadiness: Domino’s, Albertsons, and Fastenal all delivered modest beats, signalling resilient consumer spending.
What to Watch Next Week
Investors should focus on upcoming earnings from Meta Platforms (META), Tesla (TSLA), Lam Research (LRCX), GE Aerospace (GE) and Procter & Gamble (PG). These releases span social media, EVs, semiconductor equipment, aerospace and consumer staples, offering a cross‑section of market catalysts.
Frequently Asked Questions
Did Nurix Therapeutics beat Q2 2026 earnings?
Yes. Nurix reported an EPS of $4.73 versus a $0.56 loss estimate, delivering a 944.64% surprise and earning a Beat rating.
Did Goldman Sachs beat Q2 2026 earnings?
Yes. Goldman Sachs posted $17.01 EPS against an estimate of $12.90, a 31.86% beat, confirming a Beat result.
Did JPMorgan Chase miss Q2 2026 earnings?
Yes. JPM delivered $5.75 EPS compared with the $5.94 forecast, a -3.2% miss, resulting in a Miss rating.
Did UnitedHealth Group beat Q2 2026 earnings?
Yes. UnitedHealth reported $4.69 EPS versus the $4.12 estimate, a 13.83% beat, earning a Beat rating.
Did Bank of America miss Q2 2026 earnings?
Yes. Bank of America posted $1.08 EPS against the $1.11 estimate, a -2.7% miss, resulting in a Miss rating.
Did FB Financial meet Q2 2026 earnings?
Yes. FB Financial reported $1.21 EPS matching the $1.21 estimate, resulting in a Met outcome.
📅 Next Week's Key Earnings
Keep Exploring